+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Diagnostics: Technologies and Global Markets 2021-2026

  • ID: 5438484
  • Report
  • September 2021
  • Region: Global
  • 262 Pages
  • BCC Research

FEATURED COMPANIES

  • Abbott Diagnostics Inc.
  • Becton Dickinson And Co.
  • Bio-Rad
  • General Electric
  • Merck Kgaa
  • Siemens Healthineers Ag

The global tissue diagnostics market should reach $6.4 billion by 2026 from $4.7 billion in 2021 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2021 to 2026.



The general culture test segment of the global tissue diagnostics market is expected to grow from $3.0 billion in 2021 to $3.9 billion in 2026 at a CAGR of 5.4% for the forecast period of 2021 to 2026.


The AST/ID test segment of the global tissue diagnostics market is expected to grow from $1.1 billion in 2021 to $1.5 billion in 2026 at a CAGR of 7.1% for the forecast period of 2021 to 2026.


Report Scope

The scope of this study is global. The publisher analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, South Korea, Taiwan, Africa, Australia, Brazil, and Russia, among others. The report also examines market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the industry through their best practices in the research and development of tissue diagnostic tests. Excluded from this study is diagnostic testing such as imaging, veterinary diagnostics and their associated products.


This study will provide information on these areas -

  • Structure and current market size of the market for tissue diagnostics as outlined with forecasts through 2026.
  • Impact of chronic diseases, growing and aging populations.
  • Current technology and product suppliers and key innovations.
  • A look at the trends affecting the market.
  • Markets by each segment of type of test (general culture test, AST/ID tests and blood culture tests).
  • A global overview showing market data for North America, Europe, Asia-Pacific and the Rest of the World.
  • Emerging opportunities and potential investment opportunity areas for tissue diagnostics.
  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

The Report Includes:

  • 107 data tables and 28 additional tables
  • An overview of the global market for tissue diagnostic testing
  • Estimation of the market size and analyses of the global market trends, with data from 2018 to 2020, estimates for 2021 with a projection of CAGR through 2026
  • Market share analysis of tissue diagnostic testing based on type, application, end-user and geography
  • A detailed description of the three major tissue diagnostics tests, i.e., hematoxylin and eosin (H&E), immunohistochemistry (IHC) and in situ hybridization (ISH)
  • Description of molecular diagnostic tests including antigen tests, antibody (serology) tests and in vitro diagnostic testing, and information on alternative options for diagnostic tests
  • Details about the COVID-19 global pandemic, its testing basics and specific tests for the management of COVID-19 patients
  • Identification of new opportunities, challenges and technological changes within the industry
  • Assessment of regulatory structure, pricing and reimbursement scenario, pipeline analysis and FDA product approvals in 2020
  • Company profiles of major players in the market, including Abbott Diagnostics Inc., Becton, Dickinson and Co., General Electric, Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Diagnostics Inc.
  • Becton Dickinson And Co.
  • Bio-Rad
  • General Electric
  • Merck Kgaa
  • Siemens Healthineers Ag

Chapter 1 Introduction


  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Readership
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights


  • Introduction

Chapter 3 Market Landscape


  • COVID-19 Global Pandemic
  • Coronavirus Disease 2019 Testing Basics
  • Diagnostic Tests with Alternative Options
  • Molecular Diagnostic Tests
  • Increasing Access to Testing
  • Antigen Tests
  • Antibody (Serology) Tests
  • In Vitro Diagnostic Testing EUAs
  • Diagnostic Tests
  • Serology/Antibody Tests
  • Tests for the Management of COVID-19 Patients
  • Market Overview and Segmentation
  • Key Findings
  • Factors Influencing the Global Market for Tissue Diagnostics
  • Drivers
  • Challenges
  • Regulatory Landscape
  • IVD Regulations in North America
  • IVD Regulations in Europe
  • IVD Regulations in Asia-Pacific
  • IVD Regulations in Rest of the World

Chapter 4 Global Market for Tissue Diagnostics by Type of Test


  • Tissue Diagnostics
  • Trends in the Tissue Diagnostic Test Segments
  • Blood Culture
  • General Cultures (Urine/Saliva/Stool/Sputum/CSF and Other Body Fluids)
  • Identification and Antibiotic Susceptibility Testing (ID/AST)
  • FDA Product Approvals in 2020

Chapter 5 Global Market for Tissue Diagnostics by Application


  • Oncology
  • Tissue Typing
  • Pathogen Detection

Chapter 6 Global Market for Tissue Diagnostics by Region


  • Introduction
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Western Europe
  • Russia
  • Poland
  • Turkey
  • Greece
  • Czech Republic
  • Rest of Central and Eastern Europe
  • Asia-Pacific
  • Key Growth Drivers
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Taiwan
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 7 Global Market for Tissue Diagnostics by End User/End Use


  • End Users/End Uses
  • Professional Laboratories
  • Emergency Care/Bed Side/OTC/Self-testing

Chapter 8 Competitive Landscape


  • Market Share Analysis
  • Mergers and Acquisitions
  • Product Approvals

Chapter 9 Company Profiles


  • Abbott Diagnostics Inc.
  • Agilent Technologies Inc.
  • Beckman Coulter (Part Of Danaher)
  • Becton Dickinson And Co.
  • Biomerieux
  • Bio-Rad
  • General Electric
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Merck Kgaa
  • Ortho Clinical Diagnostics
  • Qiagen N.V.
  • Siemens Healthineers Ag
  • Thermo Fisher Scientific

Chapter 10 Appendix: Market Participants and List of Acronyms


  • Market Participants in Tissue Diagnostics
  • List of Acronyms

List of Tables
Summary Table A: Global Market for Tissue Diagnostics, by Region, Through 2026
Summary Table B: Global Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 1: Total COVID-19 Cases and Deaths, by WHO Region/Country, August 9, 2021
Table 2: Different Types of Coronavirus Tests, 2020
Table 3: Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2, Feb. 1, 2021
Table 4: Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2, Feb. 1, 2021
Table 5: Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2, Feb. 1, 2021
Table 6: Individual EUAs for Serology Tests for SARS-CoV-2, Feb. 1, 2021
Table 7: Individual EUAs for IVDs for the Management of COVID-19 Patients, Feb. 1, 2021
Table 8: Types of Diagnostic Tests and How They are Regulated
Table 9: Changes in IVD Regulations in Asia-Pacific, 2020
Table 10: Global Market for Tissue Diagnostics for Blood Culture, by Region, Through 2026
Table 11: Global Market for Tissue Diagnostics for General Cultures, by Region, Through 2026
Table 12: Global Market for Tissue Diagnostics for ID/AST, by Region, Through 2026
Table 13: FDA Bacteriology Products Approved in 2020
Table 14: FDA Virology Products Approved in 2020
Table 15: Global Market for Tissue Diagnostics, by Application, Through 2026
Table 16: Global Market for Tissue Diagnostics in Oncology, by Region, Through 2026
Table 17: Global Market for Tissue Diagnostics for Tissue Typing, by Region, Through 2026
Table 18: Global Market for Tissue Diagnostics for Pathogen Detection, by Region, Through 2026
Table 19: Global Market for Tissue Diagnostics, by Region, Through 2026
Table 20: North American Market for Tissue Diagnostics, by Country, Through 2026
Table 21: North American Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 22: North American Market for Tissue Diagnostics, by Application, Through 2026
Table 23: North American Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 24: U.S. Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 25: U.S. Market for Tissue Diagnostics, by Application, Through 2026
Table 26: U.S. Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 27: Canadian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 28: Canadian Market for Tissue Diagnostics, by Application, Through 2026
Table 29: Canadian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 30: Mexican Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 31: Mexican Market for Tissue Diagnostics, by Application, Through 2026
Table 32: Mexican Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 33: European Market for Tissue Diagnostics, by Country, Through 2026
Table 34: European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 35: European Market for Tissue Diagnostics, by Application, Through 2026
Table 36: European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 37: Rising Geriatric Population in Germany, 2000-2030
Table 38: Healthcare Expenditures in Germany, 2016-2020
Table 39: German Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 40: German Market for Tissue Diagnostics, by Application, Through 2026
Table 41: German Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 42: U.K. Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 43: U.K. Market for Tissue Diagnostics, by Application, Through 2026
Table 44: U.K. Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 45: Healthcare Spending and Financing in France, 2005-2020
Table 46: French Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 47: French Market for Tissue Diagnostics, by Application, Through 2026
Table 48: French Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 49: Spanish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 50: Spanish Market for Tissue Diagnostics, by Application, Through 2026
Table 51: Spanish Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 52: Italian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 53: Italian Market for Tissue Diagnostics, by Application, Through 2026
Table 54: Italian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 55: Rest of Western European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 56: Rest of Western European Market for Tissue Diagnostics, by Application, Through 2026
Table 57: Rest of Western European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 58: Russian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 59: Russian Market for Tissue Diagnostics, by Application, Through 2026
Table 60: Russian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 61: Polish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 62: Polish Market for Tissue Diagnostics, by Application, Through 2026
Table 63: Polish Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 64: Turkish Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 65: Turkish Market for Tissue Diagnostics, by Application, Through 2026
Table 66: Turkish Market for Tissue Diagnostics, by End User/End Use/End Use, Through 2026
Table 67: Greek Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 68: Greek Market for Tissue Diagnostics, by Application, Through 2026
Table 69: Greek Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 70: Czech Republic Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 71: Czech Republic Market for Tissue Diagnostics, by Application, Through 2026
Table 72: Czech Republic Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 73: Rest of Central and Eastern European Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 74: Rest of Central and Eastern European Market for Tissue Diagnostics, by Application, Through 2026
Table 75: Rest of Central and Eastern European Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 76: Asia-Pacific Market for Tissue Diagnostics, by Country, Through 2026
Table 77: Asia-Pacific Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 78: Asia-Pacific Market for Tissue Diagnostics, by Application, Through 2026
Table 79: Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 80: Chinese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 81: Chinese Market for Tissue Diagnostics, by Application, Through 2026
Table 82: Chinese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 83: Indian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 84: Indian Market for Tissue Diagnostics, by Application, Through 2026
Table 85: Indian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 86: Forecast Japanese Trends in Aging Population, 2010-2040
Table 87: Japanese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 88: Japanese Market for Tissue Diagnostics, by Application, Through 2026
Table 89: Japanese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 90: South Korean Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 91: South Korean Market for Tissue Diagnostics, by Application, Through 2026
Table 92: South Korean Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 93: Australian Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 94: Australian Market for Tissue Diagnostics, by Application, Through 2026
Table 95: Australian Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 96: Taiwanese Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 97: Taiwanese Market for Tissue Diagnostics, by Application, Through 2026
Table 98: Taiwanese Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 99: Rest of Asia-Pacific Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 100: Rest of Asia-Pacific Market for Tissue Diagnostics, by Application, Through 2026
Table 101: Rest of Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 102: Rest of the World Market for Tissue Diagnostics, by Type of Test, Through 2026
Table 103: Rest of the World Market for Tissue Diagnostics, by Application, Through 2026
Table 104: Rest of the World Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 105: Global Market for Tissue Diagnostics, by End User/End Use, Through 2026
Table 106: Global Market for Tissue Diagnostics for Professional Laboratories, by Region, Through 2026
Table 107: Global Market for Tissue Diagnostics for Emergency Care/Bed Side/OTC/ Self-testing, by Region, Through 2026
Table 108: Global Company Market Shares of Tissue Diagnostics, 2020
Table 109: Diagnostic Manufacturer Mergers and Acquisitions, 2016-2021
Table 110: U.S. FDA Approvals of High-Complexity IVD Products, 2019-2020
Table 111: Abbott Laboratories: Key Developments, 2021
Table 112: Beckman Coulter: Key Developments, 2021
Table 113: BD: Key Developments, 2021
Table 114: bioMeriux: Key Developments, 2021
Table 115: Bio-Rad: Key Developments, 2021
Table 116: General Electric: Financials, 2019
Table 117: GE Healthcare: Product Portfolio
Table 118: GE Healthcare: Recent Developments, 2021
Table 119: F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 120: F. Hoffmann-La Roche Ltd.: Revenues, by Segment, 2016-2018
Table 121: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 122: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 123: F. Hoffmann-La Roche Ltd.: Recent Developments, 2021
Table 124: Hologic: Product Portfolio
Table 125: Hologic: Financials, 2018-2020
Table 126: Hologic: Key Developments, 2021
Table 127: Siemens Healthineers AG: Key Products
Table 128: Siemens Healthineers AG: Product Segments
Table 129: Siemens Healthineers AG: Financials, 2019
Table 130: Siemens Healthineers AG: Key Developments, 2021
Table 131: Thermo Fisher Scientific Inc.: Financials, 2018 and 2019
Table 132: Thermo Fisher Scientific Inc.: Products and Services
Table 133: Thermo Fisher Scientific Inc.: Key Developments, 2021


List of Figures
Summary Figure A: Global Market for Tissue Diagnostics, by Region, 2018-2026
Summary Figure B: Global Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 1: Global Market for Tissue Diagnostics, by Type, 2018-2026
Figure 2: Global Market Shares of Clinical Microbiology Tests, by Type, 2020
Figure 3: Global Market for Tissue Diagnostics for Blood Culture, by Region, 2018-2026
Figure 4: Global Market for Tissue Diagnostics for General Cultures, by Region, 2018-2026
Figure 5: Global Market for Tissue Diagnostics for ID/AST, by Region, 2018-2026
Figure 6: Global Market for Tissue Diagnostics, by Application, 2018-2026
Figure 7: Global Market Shares of Tissue Diagnostics, by Application, 2020
Figure 8: Global Market for Tissue Diagnostics in Oncology, by Region, 2018-2026
Figure 9: Global Market for Tissue Diagnostics for Tissue Typing, by Region, 2018-2026
Figure 10: Global Market for Tissue Diagnostics for Pathogen Detection, by Region, 2018-2026
Figure 11: Global Market for Tissue Diagnostics, by Region, 2018-2026
Figure 12: North American Market for Tissue Diagnostics, by Country, 2018-2026
Figure 13: North American Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 14: North American Market for Tissue Diagnostics, by Application, 2018-2026
Figure 15: North American Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 16: U.S. Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 17: U.S. Market for Tissue Diagnostics, by Application, 2018-2026
Figure 18: U.S. Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 19: Canadian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 20: Canadian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 21: Canadian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 22: Mexican Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 23: Mexican Market for Tissue Diagnostics, by Application, 2018-2026
Figure 24: Mexican Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 25: European Market for Tissue Diagnostics, by Country, 2018-2026
Figure 26: European Market for Tissue Diagnostics, by Country, 2018-2026
Figure 27: European Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 28: European Market for Tissue Diagnostics, by Application, 2018-2026
Figure 29: European Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 30: Rising Geriatric Population in Germany, 2000-2030
Figure 31: Healthcare Expenditures in Germany, 2016-2020
Figure 32: German Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 33: German Market for Tissue Diagnostics, by Application, 2018-2026
Figure 34: German Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 35: U.K. Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 36: U.K. Market for Tissue Diagnostics, by Application, 2018-2026
Figure 37: U.K. Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 38: Healthcare Spending and Financing in France, 2005-2020
Figure 39: French Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 40: French Market for Tissue Diagnostics, by Application, 2018-2026
Figure 41: French Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 42: Spanish Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 43: Spanish Market for Tissue Diagnostics, by Application, 2018-2026
Figure 44: Spanish Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 45: Italian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 46: Italian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 47: Italian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 48: Rest of Western European Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 49: Rest of Western European Market for Tissue Diagnostics, by Application, 2018-2026
Figure 50: Rest of Western European Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 51: Russian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 52: Russian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 53: Russian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 54: Polish Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 55: Polish Market for Tissue Diagnostics, by Application, 2018-2026
Figure 56: Polish Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 57: Turkish Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 58: Turkish Market for Tissue Diagnostics, by Application, 2018-2026
Figure 59: Turkish Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 60: Greek Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 61: Greek Market for Tissue Diagnostics, by Application, 2018-2026
Figure 62: Greek Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 63: Czech Republic Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 64: Czech Republic Market for Tissue Diagnostics, by Application, 2018-2026
Figure 65: Czech Republic Market for Tissue Diagnostic Testing, by End User/End Use, 2018-2026
Figure 66: Rest of Central and Eastern European Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 67: Rest of Central and Eastern European Market for Tissue Diagnostics, by Application, 2018-2026
Figure 68: Rest of Central and Eastern European Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 69: Asia-Pacific Market for Tissue Diagnostics, by Country, 2018-2026
Figure 70: Asia-Pacific Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 71: Asia-Pacific Market for Tissue Diagnostics, by Application, 2018-2026
Figure 72: Asia-Pacific Market for Tissue Diagnostics, by Application, 2018-2026
Figure 73: Chinese Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 74: Chinese Market for Tissue Diagnostics, by Application, 2018-2026
Figure 75: Chinese Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 76: Indian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 77: Indian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 78: Indian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 79: Forecast Japanese Trends in Aging Population, 2010-2040
Figure 80: Japanese Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 81: Japanese Market for Tissue Diagnostics, by Application, 2018-2026
Figure 82: Japanese Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 83: South Korean Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 84: South Korean Market for Tissue Diagnostics, by Application, 2018-2026
Figure 85: South Korean Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 86: Australian Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 87: Australian Market for Tissue Diagnostics, by Application, 2018-2026
Figure 88: Australian Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 89: Taiwanese Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 90: Taiwanese Market for Tissue Diagnostics, by Application, 2018-2026
Figure 91: Taiwanese Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 92: Rest of Asia-Pacific Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 93: Rest of Asia-Pacific Market for Tissue Diagnostics, by Application, 2018-2026
Figure 94: Rest of Asia-Pacific Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 95: Rest of the World Market for Tissue Diagnostics, by Type of Test, 2018-2026
Figure 96: Rest of the World Market for Tissue Diagnostics, by Application, 2018-2026
Figure 97: Rest of the World Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 98: Global Market Shares of Tissue Diagnostics, by End User/End Use, 2020
Figure 99: Global Market for Tissue Diagnostics, by End User/End Use, 2018-2026
Figure 100: Global Market for Tissue Diagnostics for Professional Laboratories, byRegion, 2018-2026
Figure 101: Global Market for Tissue Diagnostics for Emergency Care/Bed Side/OTC/ Self-testing, by Region, 2018-2026
Figure 102: Global Company Market Shares of Tissue Diagnostics, 2020
Figure 103: GE Healthcare: Revenue Share, by Region/Country, 2019
Figure 104: GE Healthcare: Revenue Share, by Business Segment, 2019
Figure 105: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 106: F. Hoffmann-La Roche Ltd.: Revenue Share, by Geography, 2019
Figure 107: Siemens Healthineers AG: Revenue Share, by Business Segment, 2019
Figure 108: Siemens Healthineers AG: Revenue Share, by Region, 2019
Figure 109: Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2019


Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Abbott Diagnostics Inc.
  • Becton Dickinson And Co.
  • Bio-Rad
  • General Electric
  • Merck Kgaa
  • Siemens Healthineers Ag

The three major types of tissue diagnostics tests include:


  • Hematoxylin and eosin (H&E) is the most widely used stain in medical diagnosis, comprising about 80% of tissues used for in vitro diagnostics, and is key for highlighting structures in tissue for evaluation. In fact, virtually all patients suspected of having cancer have H&E and about 80% of cancers are diagnosed from the H&E alone.
  • Immunohistochemistry (IHC) is the process of using antibodies to stain proteins, which greatly increases the ability to identify categories of cells.
  • In situ hybridization (ISH) is an advanced technique to identify specific DNA or RNA molecules.

The most significant market trend during 2020 was the origin and global spread of COVID-19, the disease caused by the novel coronavirus. Originating in late 2019 in China, the virus quickly became a global pandemic. Global health organizations and diagnostic manufacturers quickly developed and approved tests for the virus. This effort overwhelmed all other trends in 2020. One effect of this activity was a complete halt of merger and acquisition activity among major diagnostic manufacturers in 2020.


Because of its large population and its position as a medical technology innovation hub, North America is the global leader in terms of tissue diagnostics utilization. It remains the largest market, accounting for roughly 42.0% of the total market in 2020. The emerging markets of India, China, Russia and Brazil are poised to grow at double-digit growth rates due to rising incomes, growing healthcare budgets and heightened health awareness among the population.


In Asia-Pacific, there is increasing demand for tissue diagnostic test devices, as more people are concerned about quality healthcare. Further, the expanding aging population is leading to a significant rise in the volume of clinical tests performed in laboratories. The Asia-Pacific region is currently dominated by Japan, with the largest share of revenues growing at a stable growth rate. In the coming years, however, the Asia-Pacific market is expected to be driven by emerging economies, such as China, followed by India.


Note: Product cover images may vary from those shown
  • Abbott Diagnostics Inc.
  • Agilent Technologies Inc.
  • Beckman Coulter (Part Of Danaher)
  • Becton Dickinson And Co.
  • Bio-Rad
  • Biomerieux
  • F. Hoffmann-La Roche Ltd.
  • General Electric
  • Hologic Inc.
  • Merck Kgaa
  • Ortho Clinical Diagnostics
  • Qiagen N.V.
  • Siemens Healthineers Ag
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown